The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
IDkit HP ONE
citric acid anhydrous and 13C urea · UREA C-13 75 mg/1; CITRIC ACID MONOHYDRATE 4 g/1 · Solution · Oral · Meridian Bioscience Israel Ltd
NDC 50402-0100-13 · 25 BAG in 1 BOX / 1 SOLUTION in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA021314
- TE code
- —
- Approval date
- Dec 17, 2002
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of citric acid anhydrous and 13C urea (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Meridian Bioscience Israel Ltd | UREA C-13 75 mg/1; CITRIC ACID MONOHYDRATE 4 g/1 | Aug 26, 2026 | Sep 2, 2026 |
| Meridian Bioscience Israel Ltd | UREA C-13 4 g/1; CITRIC ACID MONOHYDRATE 75 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Meridian Bioscience Israel Ltd | CITRIC ACID MONOHYDRATE 4 g/1; UREA C-13 75 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "IDkit HP ONE — NDC 50402-0100-13," retrieved September 3, 2026, https://drugdashboards.com/drug/50402010013.
Free to cite with attribution — see how the data is put together.